Mangalam Global Enterprise Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Mangalam Global Enterprise Ltd is ₹ 17.02 as of 23 Oct 15:30 . The P/E Ratio of Mangalam Global Enterprise Ltd changed from 19.8 on March 2021 to 8.1 on March 2026 . This represents a CAGR of -13.84% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Mangalam Global Enterprise Ltd changed from ₹ 574.47 crore on March 2021 to ₹ 365.81 crore on March 2026 . This represents a CAGR of -7.25% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Mangalam Global Enterprise Ltd for the Sep '26 is ₹ 983.13 crore as compare to the Jun '26 revenue of ₹ 955.33 crore. This represent the growth of 2.91% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Mangalam Global Enterprise Ltd for the Sep '26 is ₹ 23.1 crore as compare to the Jun '26 ebitda of ₹ 21.7 crore. This represent the growth of 6.45% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Mangalam Global Enterprise Ltd changed from ₹ 6.01 crore to ₹ 9.25 crore over 10 quarters. This represents a CAGR of 18.82% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The Dividend Payout of Mangalam Global Enterprise Ltd changed from 47.43 % on March 2021 to 0.8 % on March 2026 . This represents a CAGR of -49.36% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Mangalam Global Enterprise Ltd

Mangalam Global Enterprise Limited was originally incorporated as a Private Limited Company with the name 'Hindprakash Colourchem Private Limited' on September 27, 2010.
Further, the name of the Company was changed to 'Mangalam Global Enterprise Private Limited' and a fresh Certificate of Incorporation dated July 31, 2014 was issued by Registrar of Companies, Ahmedabad.
Subsequently, the Company converted into a Public Limited Company and the name was changed to 'Mangalam Global Enterprise Limited' on September 30, 2019. The Company belongs to Ahmedabad based Mangalam Group of Companies set up by Mangal Family and led by the vision of Mr. Vipin Prakash Mangal.
The Company is mainly engaged into: Manufacturing, trading and import of Edible Oil/ Non-edible oil and Agricultural Products i.e.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Mangalam Global Enterprise Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Mangalam Global Enterprise Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Mangalam Global Enterprise Ltd is 560 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Mangalam Global Enterprise Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Mangalam Global Enterprise Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Global Enterprise Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Mangalam Global Enterprise Ltd stock price is INR ₹17.02. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Mangalam Global Enterprise Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Mangalam Global Enterprise Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.